Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
1.800
+0.040 (2.27%)
At close: Nov 7, 2025, 4:00 PM EST
1.830
+0.030 (1.67%)
After-hours: Nov 7, 2025, 7:07 PM EST
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $286.37 million as of November 7, 2025. Its market cap has decreased by -56.13% in one year.
Market Cap
286.37M
Enterprise Value
230.85M
1-Year Change
-56.13%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has increased from $124.83M to $286.37M, an increase of 129.41%. That is a compound annual growth rate of 13.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 286.37M | -47.18% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | 241.63M | 276.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |